Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-01-19

Clinical Trial Update: Coenzyme Q10 as a Symptomatic Treatment in Parkinson's Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Coenzyme Q10 as a symptomatic treatment for Parkinson's disease has completed. The update notes completion status but does n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Coenzyme Q10 (Coenzyme Q10)

Snippet

Sponsor: Technische Universität Dresden | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED